<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="review-article">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">WASJ</journal-id>
<journal-title-group>
<journal-title>World Academy of Sciences Journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">2632-2900</issn>
<issn pub-type="epub">2632-2919</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">WASJ-7-1-00298</article-id>
<article-id pub-id-type="doi">10.3892/wasj.2024.298</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Acute pain in children: A reappraisal on the modalities of grade evaluation and on treatment strategies (Review)</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Di Nora</surname><given-names>Alessandra</given-names></name>
<xref rid="af1-WASJ-7-1-00298" ref-type="aff">1</xref>
<xref rid="fn1-WASJ-7-1-00298" ref-type="author-notes">*</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Sciuto</surname><given-names>Laura</given-names></name>
<xref rid="af1-WASJ-7-1-00298" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Finocchiaro</surname><given-names>Maria Carla</given-names></name>
<xref rid="af2-WASJ-7-1-00298" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Trobia</surname><given-names>Gianluca</given-names></name>
<xref rid="af2-WASJ-7-1-00298" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Minardi</surname><given-names>Carmelo</given-names></name>
<xref rid="af3-WASJ-7-1-00298" ref-type="aff">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Di Stefano</surname><given-names>Antonella</given-names></name>
<xref rid="af2-WASJ-7-1-00298" ref-type="aff">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Spampinato</surname><given-names>Serena</given-names></name>
<xref rid="af4-WASJ-7-1-00298" ref-type="aff">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Polizzi</surname><given-names>Agata</given-names></name>
<xref rid="af5-WASJ-7-1-00298" ref-type="aff">5</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ceccarelli</surname><given-names>Manuela</given-names></name>
<xref rid="af6-WASJ-7-1-00298" ref-type="aff">6</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Falsaperla</surname><given-names>Raffaele</given-names></name>
<xref rid="af7-WASJ-7-1-00298" ref-type="aff">7</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Marino</surname><given-names>Lidia</given-names></name>
<xref rid="af7-WASJ-7-1-00298" ref-type="aff">7</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Pavone</surname><given-names>Piero</given-names></name>
<xref rid="af5-WASJ-7-1-00298" ref-type="aff">5</xref>
<xref rid="af8-WASJ-7-1-00298" ref-type="aff">8</xref>
<xref rid="c1-WASJ-7-1-00298" ref-type="corresp"/>
</contrib>
</contrib-group>
<aff id="af1-WASJ-7-1-00298"><label>1</label>Postgraduate Training Program in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy</aff>
<aff id="af2-WASJ-7-1-00298"><label>2</label>Pediatric and Pediatric Emergency Room Unit, Cannizzaro Emergency Hospital Catania, I-95100 Catania, Italy</aff>
<aff id="af3-WASJ-7-1-00298"><label>3</label>Department of Anaesthesia and Intensive Care, University Hospital ‘G. Rodolico-San Marco’ Catania, I-95123 Catania, Italy</aff>
<aff id="af4-WASJ-7-1-00298"><label>4</label>Department of Clinical and Experimental Medicine, Unit of Infectious Diseases, University of Catania, ARNAS Garibaldi Hospital, I-95122 Catania, Italy</aff>
<aff id="af5-WASJ-7-1-00298"><label>5</label>Section of Pediatrics and Child Neuropsychiatry, Department of Child and Experimental Medicine, University of Catania, I-95123 Catania, Italy</aff>
<aff id="af6-WASJ-7-1-00298"><label>6</label>Faculty of Medicine and Surgery, University of Enna Kore, I-94100 Enna, Italy</aff>
<aff id="af7-WASJ-7-1-00298"><label>7</label>Pediatric, and Pediatric Emergency Department, University-Hospital ‘G. Rodolico-San Marco’, I-95123 Catania, Italy</aff>
<aff id="af8-WASJ-7-1-00298"><label>8</label>National Council of Research, Institute for Biomedical Research and Innovation (IRIB), Unit of Catania, I-95127 Catania, Italy</aff>
<author-notes>
<corresp id="c1-WASJ-7-1-00298"><italic>Correspondence to:</italic> Professor Piero Pavone, Section of Pediatrics and Child Neuropsychiatry, Department of Child and Experimental Medicine, University of Catania, Via S. Sofia 78, I-95123 Catania, Italy <email>ppavone@unict.it </email></corresp>
<fn id="fn1-WASJ-7-1-00298"><p><sup>*</sup>Contributed equally</p></fn>
</author-notes>
<pub-date pub-type="collection">
<season>Jan-Feb</season>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>25</day>
<month>11</month>
<year>2024</year></pub-date>
<volume>7</volume>
<issue>1</issue>
<elocation-id>10</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>04</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>22</day>
<month>10</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2024 Di Nora et al.</copyright-statement>
<copyright-year>2024</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
<abstract>
<p>The present review aimed to provide a summary of practical clinical approaches to the evaluation of the pain grades and modalities of treatment for pediatric patients with acute pain. For this purpose, a literature review was conducted from January, 2000 to December, 2022, which included comprehensive articles from online bibliographic databases (i.e., MEDLINE, Embase, PubMed, Cochrane Central and Scopus) covering the principal topics of pain and children OR therapeutic strategies OR pharmacological treatments OR opioid medication OR pain and nonpharmacological therapies. Different scales were used to grade acute pediatric pain, as this can range from mild to severe and may be disguised by children. In addition, non-pharmacological and pharmacological treatment modalities were reported according to the different underlying causes and types of pain. Furthermore, a list of the most well-known modalities used to measure the presence and grade of acute pain in children was compiled, and the various types of pharmacological and non-pharmacological treatments administered to children with acute pain are discussed. A flowchart for the management of children with severe pain is also presented. Acute pain in pediatric patients is a common event and a reason for concern. The causes of acute pain in children need to be carefully evaluated and appropriate treatment should be administered according to the real presence, consistency, and duration of the pain and body organ collocation.</p>
</abstract>
<kwd-group>
<kwd>pain</kwd>
<kwd>pain scales</kwd>
<kwd>pain treatment</kwd>
<kwd>acute pain</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec>
<title>1. Introduction</title>
<p>Children commonly present with acute pain that is either localized or generalized in the body. The pain may occasionally be underrated and thus inadequately treated with the possible consequence of significant issues for the health of the affected child. The revised International Association for the Study of Pain defines pain as an unpleasant sensory and emotional experience associated with or resembling that associated with actual or potential tissue damage (<xref rid="b1-WASJ-7-1-00298" ref-type="bibr">1</xref>). The clinical assessment of pain in pediatric patients must include several aspects, such as the psychological history of the child and their family, a thorough physical examination, and when necessary, laboratory analyses and radiological findings. Clinical indications should be drawn from the quality, location, duration, frequency and intensity of the pain. Pain is regarded as a symptom of an underlying condition, and perceptions of pain may be felt in accordance with different factors, such as the age, cognition, sex, previous pain experiences, temperament and psychological attitude of each patient (<xref rid="b1-WASJ-7-1-00298" ref-type="bibr">1</xref>). Pain has been temporally distinguished as acute and chronic and arbitrarily defined as acute when it lasts for 3 months and chronic when the duration is 6 months (<xref rid="b2-WASJ-7-1-00298" ref-type="bibr">2</xref>,<xref rid="b3-WASJ-7-1-00298" ref-type="bibr">3</xref>). Acute pain may also be referred to as a painful episode that is transitory and only lasts until the noxious stimulus ends or the underlying damage or pathological event(s) have been removed. Acute pain may further be a temporal manifestation of a chronic disorder.</p>
<p>Pain is a subjective experience (<xref rid="b4-WASJ-7-1-00298" ref-type="bibr">4</xref>). Despite the development and greater awareness of instruments, guidelines, and educational and training strategies, recent studies have shown that clinicians still do not pay sufficient attention to pain management, particularly in children. Inadequate clinical evaluations, inappropriate scale measurements and the treatment of acute pain in various situations have been clearly identified as contributing to this issue (<xref rid="b5-WASJ-7-1-00298" ref-type="bibr">5</xref>). In children who are &lt;2 years of age, the situation is more pronounced, as the pain, even if treated, is sometimes managed with incorrect or inadequate dosages (<xref rid="b5-WASJ-7-1-00298" ref-type="bibr">5</xref>). Acute pediatric pain evaluations must include the pain quality, characteristics, location, onset, duration, aggravating and alleviating factors, and the impact on function (<xref rid="b6-WASJ-7-1-00298 b7-WASJ-7-1-00298 b8-WASJ-7-1-00298 b9-WASJ-7-1-00298" ref-type="bibr">6-9</xref>). In children and adolescents, the intensity and quality of pain may be assessed using self-report measures, such as drawings, images of faces, graded color intensities and other systems (<xref rid="b8-WASJ-7-1-00298" ref-type="bibr">8</xref>). The aim of the present review was therefore to report the modalities used to measure the presence and grades of acute pain in children, and the different strategies to approach and treat such pain in different clinical situations. A flowchart for the management of children with severe pain is presented in <xref rid="f1-WASJ-7-1-00298" ref-type="fig">Fig. 1</xref>.</p>
</sec>
<sec>
<title>2. Literature search methods</title>
<p>A literature review was conducted by collecting articles, including clinical trials, primary research articles and reviews from online bibliographic databases (i.e., MEDLINE, Embase, PubMed, Cochrane Central and Scopus) covering the period from January, 2000 to December, 2022. The key words used for the search were derived from medical subject heading terms, namely ‘pain and children (pediatric)’, ‘pediatric’, ‘child’, ‘infant’, ‘toddler’ OR pain therapeutic strategies (‘analgesic’ or ‘analgesia’) OR pain pharmacological treatments OR opioid medications OR pain and nonpharmacological therapies. Relevant studies were examined manually and are included in the present reference list. As the subject of the present study was notably wide, the literature data that were included were those that were, in the authors' opinion, more representative.</p>
<p>Once the initial results had been collected, two reviewers analyzed the titles and abstracts and screened them for the inclusion criteria, which were studies with any level of evidence that reported clinical results published over the past 22 years (2000-2022). Comparative, cross-sectional, retrospective, prospective and survey studies, case series, and case reports on the pediatric population were included. All the articles written in languages other than English were excluded. Articles that dealt with different topics, had poor scientific methodologies, or were without an accessible abstract were also excluded. In addition, articles that did not match the inclusion criteria were ruled out. After removing the duplicate records, the main search articles that related to the study were included.</p>
</sec>
<sec>
<title>3. Acute pain in children</title>
<p>Diverse events cause acute pain in children, which affects various body organs and requires treatment by different types of specialists. Numerous clinical studies have addressed scale measurements of pain and clinical trials for pain treatment. However, to the best of our knowledge, no common agreement has been reached on the methods to use to measure pain in children or treatment strategies, although several options have been proposed for each topic. The present literature review indicates that a wide range of scales are used to measure acute pediatric pain, with different options employed for pharmacological and non-pharmacological treatment strategies.</p>
<p>The causes and treatment of acute pain are significant challenges, particularly among children and adolescents. Current guidelines recommend assessing and relieving (<xref rid="b1-WASJ-7-1-00298" ref-type="bibr">1</xref>,<xref rid="b3-WASJ-7-1-00298" ref-type="bibr">3</xref>,<xref rid="b8-WASJ-7-1-00298" ref-type="bibr">8</xref>) pain in all children in all instances; yet in clinical practice, particularly in the pediatric population, management is suboptimal and not completed (<xref rid="b5-WASJ-7-1-00298" ref-type="bibr">5</xref>). In a survey of acute pain management in children that involved 929 Italian pediatricians, Marseglia <italic>et al</italic> (<xref rid="b10-WASJ-7-1-00298" ref-type="bibr">10</xref>) reported the results obtained for 6,335 patients with a uniform distribution of different types of acute pain. Pain was more frequently found to be of moderate intensity (42.2%, P&lt;0.001) and a short duration (within a few days: 98.4%, P&lt;0.001). Only 50.1% of the respondents used an algometric scale to measure pain, and 60.5% always prescribed a treatment. In the group of children with mild to moderate pain (n=4,438), the most commonly used first-line nonopioid treatments were ibuprofen (53.3%) and acetaminophen (44.4%) (<xref rid="b10-WASJ-7-1-00298" ref-type="bibr">10</xref>). In the authors' experience, analgesics can be used without causing complications; however, the side-effects of these analgesics should be taken into consideration, as these can aggravate issues that already present in patients with comorbidities. For example, non-steroidal anti-inflammatory drugs (NSAIDs), cause gastric toxicity, which adds to basic reflux, and a reduction in renal flow, which adds to the poor intake of water. The hepatotoxic effect of paracetamol can contribute to malnutrition and the effects of cytochrome inhibitor drugs. Opioids can worsen constipation, nausea and dystonia and can cause itching, which the child will not be able to scratch, as well as urinary retention (globus vesicalis), particularly if the child is receiving glycopyrrolate therapy.</p>
<p>The World Health Organization (WHO) recommends a step approach, with pain divided into mild, moderate and severe (<xref rid="b11-WASJ-7-1-00298" ref-type="bibr">11</xref>). In the case of mild pain, the suggested treatment is non-opioid medications. For moderate pain, weak opioids should be used, with strong opioids used for severe pain. The most difficult task in the evaluation is the individuation of the pain condition and the application of the appropriate therapy.</p>
<p>In the assessment of acute pain in children, among the other key factors, are the evaluation of the grade of the pain and the correct treatment required for its attenuation or cessation.</p>
</sec>
<sec>
<title>4. Scales for pain grade measurement in pediatric patients</title>
<p>Various tools are available to measure the grades of acute pain in children. A list of scales to measure the properties of self-reported pain intensity is presented in <xref rid="tI-WASJ-7-1-00298" ref-type="table">Table I</xref>. No single scale is advocated as optimal for use with all types of pain or across the developmental age span. Scales must be applied with due consideration of several factors, including the age of the child, the clinical localization and severity of the pain, and the cognitive and psychological structure of the child (<xref rid="b9-WASJ-7-1-00298" ref-type="bibr">9</xref>,<xref rid="b12-WASJ-7-1-00298 b13-WASJ-7-1-00298 b14-WASJ-7-1-00298" ref-type="bibr">12-14</xref>). In children with neurocognitive disabilities and in the context of emergency rooms/urgent situations, the measurement of the severity of pain becomes more complex and difficult. The inability/difficulty of children to communicate verbally or non-verbally, the presence of stereotyped or involuntary movements, altered facial and body expressiveness, and sensory disabilities may limit the validity of pain measurement.</p>
</sec>
<sec>
<title>5. Therapeutic strategies</title>
<p>Various types of acute pediatric treatments are available depending on the age of the patient, the intensity of the pain, and the characteristics and types of organs affected. As the topic is extremely wide, the present review summarizes the treatment strategies more frequently used. The therapeutic strategies can be divided into non-pharmacological techniques and pharmacological drugs. The use of several other analgesics is not considered (e.g., nitrous oxide, methoxyflurane, ketamine, diamorphine) as this was beyond the scope of the present review.</p>
<sec>
<title/>
<sec>
<title>Non-pharmacological techniques</title>
<p>Research has shown that non-pharmacological options, including physical and psychological strategies, may be helpful in treating pain. Children may benefit from cognitive behavioral strategies, such as the use of imagery or relaxation. The application of non-pharmacological techniques has been employed to control pain, stress, and anxiety in children and their parents (<xref rid="b9-WASJ-7-1-00298" ref-type="bibr">9</xref>). The present review provides a summary of some of the suggested non-pharmacological strategies aimed at the attenuation or cessation of acute pain in children. In their review of 39 trials with 3,394 participants, Uman <italic>et al</italic> (<xref rid="b15-WASJ-7-1-00298" ref-type="bibr">15</xref>) examined the effects of psychological interventions on needle-related procedural pain and distress in children and adolescents aged 2-19 years. They found strong evidence in support of distraction and hypnosis for needle-related pain and distress in this population (<xref rid="b15-WASJ-7-1-00298" ref-type="bibr">15</xref>). Similarly, Accardi and Milling (<xref rid="b16-WASJ-7-1-00298" ref-type="bibr">16</xref>) reported the effectiveness of hypnosis in reducing procedure-related pain in children. A systematic literature search on non-pharmacological interventions used for pain management in children in emergency departments was conducted by Wente (<xref rid="b9-WASJ-7-1-00298" ref-type="bibr">9</xref>). Among the 14 articles examined, distraction was used in 10 studies, sucrose in two studies, cold application in one study, and parental holding and positioning in one study. Furthermore, decreased pain, distress and anxiety in the parent, child, and/or observer were noted when these procedures were used (<xref rid="b9-WASJ-7-1-00298" ref-type="bibr">9</xref>). Cognitive-behavioral strategies should be related to the age and degree of cognitive development of the patient: The oral administration of sucrose and glucose, kangaroo care, tactile stimulation, rocking, singing and soft music, and an environment with soft, fused lights can be effective for infants. For children of school age, the application of cold spray, ice, hot moist packs, massaging and pressure can be useful and satisfying. Furthermore, the use of bandages, dressings and splints are other simple systems that can be used to reduce pain symptoms and anxiety, as these cover the view of the ‘wound’ that is causing psychophysical distress in the child (<xref rid="b2-WASJ-7-1-00298" ref-type="bibr">2</xref>). A study involving 98 children and 97 control children/parents examined the beliefs of parents about pain and the efficacy of a parental educational intervention on pain intensity in children and the experience of pain-related unpleasantness at 24 h post-discharge from the emergency department (<xref rid="b17-WASJ-7-1-00298" ref-type="bibr">17</xref>). According to the researchers, the active participation of parents in their child's pain management may be more effective than a passive educational intervention (<xref rid="b17-WASJ-7-1-00298" ref-type="bibr">17</xref>). Music therapy has also been shown to be a form of distraction that alleviates some types of pain and distress experienced by children undergoing medical procedures in a pediatric emergency department (<xref rid="b18-WASJ-7-1-00298" ref-type="bibr">18</xref>). In a previous comprehensive review that included 13 studies and involved 778 patients, the effects of music therapy and opioid treatment on pain anxiety among patients who underwent orthopedic surgery were evaluated. Significant differences were found between the two groups regarding the use of music therapy to reduce pain; however, no statistically significant differences were found in the use of opioids and physiological variables between the two groups. The authors maintained that the timing, duration, and type of music intervention can be modified in relation to specific clinical settings and medical teams (<xref rid="b19-WASJ-7-1-00298" ref-type="bibr">19</xref>). A summary of the non-pharmacological techniques used for pain management in children is presented in <xref rid="tII-WASJ-7-1-00298" ref-type="table">Table II</xref>.</p>
<p>Criticism has been expressed as regards the use of non-pharmacological treatments in the context of acute pediatric pain where pharmacological, physical (splint, ice) and psychological (distraction, breathing) treatments may be more effective. In addition, the literature provides evidence of the difficulties faced by nurses in applying non-pharmacological treatments due to inadequate cooperation from physicians, the heavy workloads of nurses and multiple responsibilities, the low ratio of nurses per patient, and the unfavorable attitudes of nurses to non-pharmacological pain management (<xref rid="b20-WASJ-7-1-00298" ref-type="bibr">20</xref>).</p>
</sec>
<sec>
<title>Pharmacological strategies</title>
<p>Pharmacological therapies are the most commonly used types of treatments for any type of pain. The drugs commonly utilized, as well as the routes of administration, doses and indications on their use are summarized in <xref rid="tIII-WASJ-7-1-00298" ref-type="table">Table III</xref>.</p>
<p><italic>Non-opioid medications</italic>. The non-opioid pain medications most commonly used are NSAIDs, which act via their inhibitory actions on cyclooxygenase (COX)-2 enzymes. COX-2 enzymes facilitate the production of pro-inflammatory prostaglandins; thus, prostaglandin production is inhibited to obtain an analgesic effect. Among the most commonly used NSAIDs is ibuprofen. Other COX-2 inhibitors, such as indomethacin, meloxicam and Celebrex, are more frequently used to treat inflammatory and rheumatological disorders than acute pain (20,21A previous randomized controlled trial of acetaminophen, ibuprofen and codeine treatment for acute pain in children with musculoskeletal trauma conducted by Clark <italic>et al</italic> (<xref rid="b21-WASJ-7-1-00298" ref-type="bibr">21</xref>) involved 336 pediatric patients with 100 children in each treatment group. According to the authors of that study, ibuprofen provided the optimal analgesic effect of the three medications studied. In another study, a group of children presenting with uncomplicated extremity fractures was treated in a randomized trial with the oral administration of either morphine or ibuprofen (<xref rid="b22-WASJ-7-1-00298" ref-type="bibr">22</xref>). In that trial, 66 children were in the morphine group and 68 in the ibuprofen group. No significant differences in analgesic efficacy were reported between the groups, although morphine was associated with a significantly greater number of adverse effects. The authors of that study maintained that ibuprofen remains safe and effective for outpatient pain management in children with uncomplicated fractures (<xref rid="b22-WASJ-7-1-00298" ref-type="bibr">22</xref>). In another randomized clinical trial performed by Chang <italic>et al</italic> (<xref rid="b23-WASJ-7-1-00298" ref-type="bibr">23</xref>), of 411 patients with acute extremity pain (mean score, 8.7 on an 11-point numerical rating scale) in an emergency department, no significant differences in pain reduction at 2 h were found. The main pain scores decreased by 4.3 with ibuprofen and acetaminophen, 4.4 with oxycodone and acetaminophen, 3.5 with hydrocodone and acetaminophen, and 3.9 with codeine and acetaminophen. According to the authors of that study, the analgesic effects of NSAIDs were equally efficacious as opioids when treating musculoskeletal pain in adult patients (<xref rid="b23-WASJ-7-1-00298" ref-type="bibr">23</xref>).</p>
<p>As is well known, the use of ibuprofen is not recommended for patients with hemorrhagic pathologies, significant dehydration, gastrointestinal disorders and impaired renal function. Jelinek (<xref rid="b24-WASJ-7-1-00298" ref-type="bibr">24</xref>) demonstrated that the intravenous administration of ketorolac exhibited an equivalent efficacy in reducing moderate to severe pain as intravenous morphine, although with fewer side-effects. Marzuillo <italic>et al</italic> (<xref rid="b25-WASJ-7-1-00298" ref-type="bibr">25</xref>) reviewed the pharmacokinetics of ketorolac and confirmed its efficacy without severe side-effects, if used for a short period of time. Recently, a pilot single central randomized controlled trial demonstrated that ketorolac had comparable results to morphine when used in children aged 6-17 years with suspected appendicitis (<xref rid="b26-WASJ-7-1-00298" ref-type="bibr">26</xref>). The use of ketorolac sublingually as a valid alternative in the absence of intravenous access was also suggested (<xref rid="b26-WASJ-7-1-00298" ref-type="bibr">26</xref>). Neri <italic>et al</italic> (<xref rid="b27-WASJ-7-1-00298" ref-type="bibr">27</xref>) demonstrated that sublingual ketorolac and tramadol were equally effective. In cases of suspected bone fractures, studies have shown that sublingual ketorolac and tramadol are effective analgesics for pain management in children aged 4-17 years (<xref rid="b25-WASJ-7-1-00298" ref-type="bibr">25</xref>,<xref rid="b26-WASJ-7-1-00298" ref-type="bibr">26</xref>).</p>
<p>Paracetamol has been cited in numerous studies as the first-line analgesic agent in emergency departments. Its efficacy is valuable at the correct dose (15 mg/kg) in the treatment of mild to moderate pain. It is characterized by its rapid action and the possibility of different routes of administration (<xref rid="b28-WASJ-7-1-00298" ref-type="bibr">28</xref>). A previous meta-analysis revealed that the safety and tolerability profiles of paracetamol and ibuprofen were similar in terms of their efficacy for both pain and fever, and they were rarely associated with severe side-effects (<xref rid="b28-WASJ-7-1-00298" ref-type="bibr">28</xref>). In instances of mild or moderate pain, it is preferable to administer paracetamol <italic>per os</italic> to achieve fairly rapid action and excellent tolerance in the majority of children. By contrast, the rectal route is burdened by slow absorption and unpredictable efficacy both with respect to action time and analgesic capacity (<xref rid="b29-WASJ-7-1-00298" ref-type="bibr">29</xref>). In a multicenter emergency department study in 2018, Benini <italic>et al</italic> (<xref rid="b7-WASJ-7-1-00298" ref-type="bibr">7</xref>) found that both paracetamol and ibuprofen were inappropriately used in 83 and 63% of pediatric cases, respectively.</p>
<p>Ketamine, a drug that blocks the effects of glutamate, has been shown to be an effective analgesic in children when administered at sub-dissociative doses (<xref rid="b30-WASJ-7-1-00298" ref-type="bibr">30</xref>). Back pain, headache, extremity or musculoskeletal pain, acute abdominal pain and renal colic are controlled by the intravenous administration of ketamine when used appropriately (<xref rid="b31-WASJ-7-1-00298" ref-type="bibr">31</xref>,<xref rid="b32-WASJ-7-1-00298" ref-type="bibr">32</xref>). In recent years, two systematic reviews and meta-analyses demonstrated that ketamine was non-inferior to opioid medications for acute pain management, as it had a similar analgesic effect and safety profile (<xref rid="b33-WASJ-7-1-00298" ref-type="bibr">33</xref>,<xref rid="b34-WASJ-7-1-00298" ref-type="bibr">34</xref>).</p>
<p><italic>Opioid medications</italic>. Opioid infusion is usually indicated for patients with chronic pain. OF note, a bolus of an intravenous opioid is advised for patients with sudden-onset severe pain or reserved for breakthrough pain for patients who are already receiving opioid infusions. Researchers have recommended that the starting opioid in opioid-naïve patients should be morphine or hydromorphone (<xref rid="b30-WASJ-7-1-00298" ref-type="bibr">30</xref>). Typically, immediate-release oral opioids are ordered for pain at intervals of 3-4 h to minimize breakthrough pain and opioid side-effects (<xref rid="b30-WASJ-7-1-00298" ref-type="bibr">30</xref>). Additional smaller doses can be administered every 2 h for breakthrough doses. In general, oral use is preferred over intravenous administration, except in cases of poor absorption or an inability to administer drugs enterally (i.e., colitis, mucositis, vomiting). The sublingual route of administration is safe and efficacious both for ketorolac and opioids (<xref rid="b34-WASJ-7-1-00298" ref-type="bibr">34</xref>,<xref rid="b35-WASJ-7-1-00298" ref-type="bibr">35</xref>). In the trauma setting, intranasal sufentanil or diamorphine administration have both been reported as highly efficacious in the treatment of severe pain (<xref rid="b36-WASJ-7-1-00298" ref-type="bibr">36</xref>,<xref rid="b37-WASJ-7-1-00298" ref-type="bibr">37</xref>).</p>
</sec>
</sec>
</sec>
<sec>
<title>6. Conclusion</title>
<p>The role of the pediatricians in the treatment of acute pain is extremely complex due to the poor collaboration of and difficulties encountered by the children and their parents to correctly indicate the duration, intensity and localization of the pain. The task of pediatricians consists of carefully evaluating the underlying cause for acute pain in children to consequently administer appropriate treatment. The list of methodologies used to reveal the scales of acute pain and the type of treatment to be used for specific causes of acute pain is wide. Thus, treatment needs to be carried out according to the duration, localization and severity of the pain, reflecting the experience of the single pediatric specialist.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Authors' contributions</title>
<p>PP, RF, LM, MCF and ADN conceived and designed the study. GT and ADS performed the literature search. CM, LS and MCF analyzed the data obtained from the literature. PP, AP and RF wrote the manuscript. All authors (ADN, LS, MCF, GT, CM, ADS, SS, AP, MC, RF, LM and PP) were involved in the preparation of the final draft and in the revision of the manuscript. Data authentication is not applicable.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-WASJ-7-1-00298"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raja</surname><given-names>SN</given-names></name><name><surname>Carr</surname><given-names>DB</given-names></name><name><surname>Cohen</surname><given-names>M</given-names></name><name><surname>Finnerup</surname><given-names>NB</given-names></name><name><surname>Flor</surname><given-names>H</given-names></name><name><surname>Gibson</surname><given-names>S</given-names></name><name><surname>Keefe</surname><given-names>FJ</given-names></name><name><surname>Mogil</surname><given-names>JS</given-names></name><name><surname>Ringkamp</surname><given-names>M</given-names></name><name><surname>Sluka</surname><given-names>KA</given-names></name><etal/></person-group><article-title>The revised international association for the study of pain definition of pain: Concepts, challenges, and compromises</article-title><source>Pain</source><volume>161</volume><fpage>1976</fpage><lpage>1982</lpage><year>2020</year><pub-id pub-id-type="pmid">32694387</pub-id><pub-id pub-id-type="doi">10.1097/j.pain.0000000000001939</pub-id></element-citation></ref>
<ref id="b2-WASJ-7-1-00298"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coda</surname><given-names>BA</given-names></name><name><surname>Bonica</surname><given-names>JJ</given-names></name></person-group><comment>General considerations of acute pain. In: Loeser JD, Butler SH, Chapman CR and Turk DC (eds) Bonica's management of pain, 3rd edition. Philadelphia: Lippincott Williams &amp; Wilkins, pp222-240, 2001.</comment></element-citation></ref>
<ref id="b3-WASJ-7-1-00298"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>KA</given-names></name></person-group><article-title>Pain in children. Children can experience a wide variety of painful conditions-from migraine headaches to growing pains</article-title><source>Pract Pain Manag</source><volume>15</volume><fpage>1</fpage><lpage>18</lpage><year>2015</year></element-citation></ref>
<ref id="b4-WASJ-7-1-00298"><label>4</label><element-citation publication-type="journal"><comment>American Academy of Pediatrics. Committee on Psychosocial Aspects of Child and Family Health; Task Force on Pain in Infants, Children, and Adolescents</comment><article-title>The assessment and management of acute pain in infants, children, and adolescents</article-title><source>Pediatrics</source><volume>108</volume><fpage>793</fpage><lpage>497</lpage><year>2001</year><pub-id pub-id-type="pmid">11533354</pub-id><pub-id pub-id-type="doi">10.1542/peds.108.3.793</pub-id></element-citation></ref>
<ref id="b5-WASJ-7-1-00298"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathews</surname><given-names>L</given-names></name></person-group><article-title>Pain in children: Neglected, unaddressed and mismanaged</article-title><source>Indian J Palliat Care</source><volume>17 (Suppl)</volume><fpage>S70</fpage><lpage>S73</lpage><year>2011</year><pub-id pub-id-type="pmid">21811376</pub-id><pub-id pub-id-type="doi">10.4103/0973-1075.76247</pub-id></element-citation></ref>
<ref id="b6-WASJ-7-1-00298"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrante</surname><given-names>P</given-names></name><name><surname>Cuttini</surname><given-names>M</given-names></name><name><surname>Zangardi</surname><given-names>T</given-names></name><name><surname>Tomasello</surname><given-names>C</given-names></name><name><surname>Messi</surname><given-names>G</given-names></name><name><surname>Pirozzi</surname><given-names>N</given-names></name><name><surname>Losacco</surname><given-names>V</given-names></name><name><surname>Piga</surname><given-names>S</given-names></name><name><surname>Benini</surname><given-names>F</given-names></name></person-group><comment>PIPER Study Group</comment><article-title>Pain management policies and practices in pediatric emergency care: A nationwide survey of Italian hospitals</article-title><source>BMC Pediatr</source><volume>13</volume><issue>139</issue><year>2013</year><pub-id pub-id-type="pmid">24020369</pub-id><pub-id pub-id-type="doi">10.1186/1471-2431-13-139</pub-id></element-citation></ref>
<ref id="b7-WASJ-7-1-00298"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benini</surname><given-names>F</given-names></name><name><surname>Castagno</surname><given-names>E</given-names></name><name><surname>Barbi</surname><given-names>E</given-names></name><name><surname>Congedi</surname><given-names>S</given-names></name><name><surname>Urbino</surname><given-names>A</given-names></name><name><surname>Biban</surname><given-names>P</given-names></name><name><surname>Calistri</surname><given-names>L</given-names></name><name><surname>Mancusi</surname><given-names>RL</given-names></name></person-group><article-title>Multicentre emergency department study found that paracetamol and ibuprofen were inappropriately used in 83 and 63% of paediatric cases</article-title><source>Acta Paediatr</source><volume>107</volume><fpage>1766</fpage><lpage>1774</lpage><year>2018</year><pub-id pub-id-type="pmid">29505669</pub-id><pub-id pub-id-type="doi">10.1111/apa.14306</pub-id></element-citation></ref>
<ref id="b8-WASJ-7-1-00298"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gai</surname><given-names>N</given-names></name><name><surname>Naser</surname><given-names>B</given-names></name><name><surname>Hanley</surname><given-names>J</given-names></name><name><surname>Peliowski</surname><given-names>A</given-names></name><name><surname>Hayes</surname><given-names>J</given-names></name><name><surname>Aoyama</surname><given-names>K</given-names></name></person-group><article-title>A practical guide to acute pain management in children</article-title><source>J Anesth</source><volume>34</volume><fpage>421</fpage><lpage>433</lpage><year>2020</year><pub-id pub-id-type="pmid">32236681</pub-id><pub-id pub-id-type="doi">10.1007/s00540-020-02767-x</pub-id></element-citation></ref>
<ref id="b9-WASJ-7-1-00298"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wente</surname><given-names>SJK</given-names></name></person-group><article-title>Nonpharmacologic pediatric pain management in emergency departments: A systematic review of the literature</article-title><source>J Emerg Nurs</source><volume>39</volume><fpage>140</fpage><lpage>150</lpage><year>2013</year><pub-id pub-id-type="pmid">23199786</pub-id><pub-id pub-id-type="doi">10.1016/j.jen.2012.09.011</pub-id></element-citation></ref>
<ref id="b10-WASJ-7-1-00298"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marseglia</surname><given-names>GL</given-names></name><name><surname>Alessio</surname><given-names>M</given-names></name><name><surname>Da Dalt</surname><given-names>L</given-names></name><name><surname>Giuliano</surname><given-names>M</given-names></name><name><surname>Ravelli</surname><given-names>A</given-names></name><name><surname>Marchisio</surname><given-names>P</given-names></name></person-group><article-title>Acute pain management in children: A survey of Italian pediatricians</article-title><source>Ital J Pediatr</source><volume>45</volume><issue>156</issue><year>2013</year><pub-id pub-id-type="pmid">31796092</pub-id><pub-id pub-id-type="doi">10.1186/s13052-019-0754-3</pub-id></element-citation></ref>
<ref id="b11-WASJ-7-1-00298"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ventafridda</surname><given-names>V</given-names></name><name><surname>Saita</surname><given-names>L</given-names></name><name><surname>Ripamonti</surname><given-names>C</given-names></name><name><surname>De Conno</surname><given-names>F</given-names></name></person-group><article-title>WHO guidelines for the use of analgesics in cancer pain</article-title><source>Int J Tissue React</source><volume>7</volume><fpage>93</fpage><lpage>96</lpage><year>1985</year><pub-id pub-id-type="pmid">2409039</pub-id></element-citation></ref>
<ref id="b12-WASJ-7-1-00298"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birnie</surname><given-names>KA</given-names></name><name><surname>Hundert</surname><given-names>AS</given-names></name><name><surname>Lalloo</surname><given-names>C</given-names></name><name><surname>Nguyen</surname><given-names>C</given-names></name><name><surname>Stinson</surname><given-names>JN</given-names></name></person-group><article-title>Recommendations for selection of self-report pain intensity measures in children and adolescents: A systematic review and quality assessment of measurement properties</article-title><source>Pain</source><volume>160</volume><fpage>5</fpage><lpage>18</lpage><year>2019</year><pub-id pub-id-type="pmid">30180088</pub-id><pub-id pub-id-type="doi">10.1097/j.pain.0000000000001377</pub-id></element-citation></ref>
<ref id="b13-WASJ-7-1-00298"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinson</surname><given-names>JN</given-names></name><name><surname>Kavanagh</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>J</given-names></name><name><surname>Gill</surname><given-names>N</given-names></name><name><surname>Stevens</surname><given-names>B</given-names></name></person-group><article-title>Systematic review of the psychometric properties, interpretability and feasibility of self-report pain intensity measures for use in clinical trials in children and adolescents</article-title><source>Pain</source><volume>125</volume><fpage>143</fpage><lpage>157</lpage><year>2006</year><pub-id pub-id-type="pmid">16777328</pub-id><pub-id pub-id-type="doi">10.1016/j.pain.2006.05.006</pub-id></element-citation></ref>
<ref id="b14-WASJ-7-1-00298"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulloch</surname><given-names>B</given-names></name><name><surname>Garcia-Filion</surname><given-names>P</given-names></name><name><surname>Notricia</surname><given-names>D</given-names></name><name><surname>Bryson</surname><given-names>M</given-names></name><name><surname>McConahay</surname><given-names>T</given-names></name></person-group><article-title>Reliability of the color analog scale: Repeatability of scores in traumatic and nontraumatic injuries</article-title><source>Acad Emerg Med</source><volume>16</volume><fpage>465</fpage><lpage>469</lpage><year>2009</year><pub-id pub-id-type="pmid">19388922</pub-id><pub-id pub-id-type="doi">10.1111/j.1553-2712.2009.00404.x</pub-id></element-citation></ref>
<ref id="b15-WASJ-7-1-00298"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uman</surname><given-names>LS</given-names></name><name><surname>Chambers</surname><given-names>CT</given-names></name><name><surname>McGrath</surname><given-names>PJ</given-names></name><name><surname>Kisely</surname><given-names>SR</given-names></name></person-group><comment>Psychological interventions for needle-related procedural pain and distress in children and adolescents. Cochrane Database Syst Rev: CD005179, 2006.</comment></element-citation></ref>
<ref id="b16-WASJ-7-1-00298"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Accardi</surname><given-names>MC</given-names></name><name><surname>Milling</surname><given-names>LS</given-names></name></person-group><article-title>The effectiveness of hypnosis for reducing procedure-related pain in children and adolescents: A comprehensive methodological review</article-title><source>J Behav Med</source><volume>32</volume><fpage>328</fpage><lpage>339</lpage><year>2009</year><pub-id pub-id-type="pmid">19255840</pub-id><pub-id pub-id-type="doi">10.1007/s10865-009-9207-6</pub-id></element-citation></ref>
<ref id="b17-WASJ-7-1-00298"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeMay</surname><given-names>S</given-names></name><name><surname>Johnston</surname><given-names>C</given-names></name><name><surname>Choinière</surname><given-names>M</given-names></name><name><surname>Fortin</surname><given-names>C</given-names></name><name><surname>Hubert</surname><given-names>I</given-names></name><name><surname>Fréchette</surname><given-names>G</given-names></name><name><surname>Kudirka</surname><given-names>D</given-names></name><name><surname>Murray</surname><given-names>L</given-names></name></person-group><article-title>Pain management interventions with parents in the emergency department: A randomized trial</article-title><source>J Adv Nurs</source><volume>66</volume><fpage>2442</fpage><lpage>2449</lpage><year>2010</year><pub-id pub-id-type="pmid">20722814</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2648.2010.05408.x</pub-id></element-citation></ref>
<ref id="b18-WASJ-7-1-00298"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartling</surname><given-names>L</given-names></name><name><surname>Newton</surname><given-names>AS</given-names></name><name><surname>Liang</surname><given-names>Y</given-names></name><name><surname>Jou</surname><given-names>H</given-names></name><name><surname>Hewson</surname><given-names>K</given-names></name><name><surname>Klassen</surname><given-names>TP</given-names></name><name><surname>Curtis</surname><given-names>S</given-names></name></person-group><article-title>Music to reduce pain and distress in the pediatric emergency department: A randomized clinical trial</article-title><source>JAMA Pediatr</source><volume>167</volume><fpage>826</fpage><lpage>835</lpage><year>2013</year><pub-id pub-id-type="pmid">23857075</pub-id><pub-id pub-id-type="doi">10.1001/jamapediatrics.2013.200</pub-id></element-citation></ref>
<ref id="b19-WASJ-7-1-00298"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patiyal</surname><given-names>N</given-names></name><name><surname>Kalyani</surname><given-names>V</given-names></name><name><surname>Mishra</surname><given-names>R</given-names></name><name><surname>Kataria</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Parashar</surname><given-names>A</given-names></name><name><surname>Kumari</surname><given-names>P</given-names></name></person-group><article-title>Effect of music therapy on pain, anxiety, and use of opioids among patients underwent orthopedic surgery: A systematic review and meta-analysis</article-title><source>Cureus</source><volume>13</volume><issue>e18377</issue><year>2021</year><pub-id pub-id-type="pmid">34725621</pub-id><pub-id pub-id-type="doi">10.7759/cureus.18377</pub-id></element-citation></ref>
<ref id="b20-WASJ-7-1-00298"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeleke</surname><given-names>S</given-names></name><name><surname>Kassaw</surname><given-names>A</given-names></name><name><surname>Eshetie</surname><given-names>Y</given-names></name></person-group><article-title>Non-pharmacological pain management practice and barriers among nurses working in debre tabor comprehensive specialized hospital, ethiopia</article-title><source>PLoS One</source><volume>16</volume><issue>e0253086</issue><year>2021</year><pub-id pub-id-type="pmid">34129616</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0253086</pub-id></element-citation></ref>
<ref id="b21-WASJ-7-1-00298"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname><given-names>E</given-names></name><name><surname>Plint</surname><given-names>AC</given-names></name><name><surname>Correll</surname><given-names>R</given-names></name><name><surname>Gaboury</surname><given-names>I</given-names></name><name><surname>Passi</surname><given-names>B</given-names></name></person-group><article-title>A randomized, controlled trial of acetaminophen, ibuprofen, and codeine for acute pain relief in children with musculoskeletal trauma</article-title><source>Pediatrics</source><volume>119</volume><fpage>460</fpage><lpage>467</lpage><year>2007</year><pub-id pub-id-type="pmid">17332198</pub-id><pub-id pub-id-type="doi">10.1542/peds.2006-1347</pub-id></element-citation></ref>
<ref id="b22-WASJ-7-1-00298"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poonai</surname><given-names>N</given-names></name><name><surname>Bhullar</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>K</given-names></name><name><surname>Papini</surname><given-names>A</given-names></name><name><surname>Mainprize</surname><given-names>D</given-names></name><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Teefy</surname><given-names>J</given-names></name><name><surname>Bale</surname><given-names>M</given-names></name><name><surname>Langford</surname><given-names>C</given-names></name><name><surname>Lim</surname><given-names>R</given-names></name><etal/></person-group><article-title>Oral administration of morphine versus ibuprofen to manage postfracture pain in children: A randomized trial</article-title><source>CMAJ</source><volume>186</volume><fpage>1358</fpage><lpage>1363</lpage><year>2014</year><pub-id pub-id-type="pmid">25349008</pub-id><pub-id pub-id-type="doi">10.1503/cmaj.140907</pub-id></element-citation></ref>
<ref id="b23-WASJ-7-1-00298"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>AK</given-names></name><name><surname>Bijur</surname><given-names>PE</given-names></name><name><surname>Esses</surname><given-names>D</given-names></name><name><surname>Barnaby</surname><given-names>DP</given-names></name><name><surname>Baer</surname><given-names>J</given-names></name></person-group><article-title>Effect of a single dose of oral opioid and nonopioid analgesics on acute extremity pain in the emergency department: A randomized clinical trial</article-title><source>JAMA</source><volume>318</volume><fpage>1661</fpage><lpage>1667</lpage><year>2017</year><pub-id pub-id-type="pmid">29114833</pub-id><pub-id pub-id-type="doi">10.1001/jama.2017.16190</pub-id></element-citation></ref>
<ref id="b24-WASJ-7-1-00298"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jelinek</surname><given-names>GA</given-names></name></person-group><article-title>Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects</article-title><source>BMJ</source><volume>321</volume><fpage>1236</fpage><lpage>1237</lpage><year>2000</year><pub-id pub-id-type="pmid">11082068</pub-id><pub-id pub-id-type="doi">10.1136/bmj.321.7271.1236</pub-id></element-citation></ref>
<ref id="b25-WASJ-7-1-00298"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marzuillo</surname><given-names>P</given-names></name><name><surname>Calligaris</surname><given-names>L</given-names></name><name><surname>Amoroso</surname><given-names>S</given-names></name><name><surname>Barbi</surname><given-names>E</given-names></name></person-group><article-title>Narrative review shows that the short-term use of ketorolac is safe and effective in the management of moderate-to-severe pain in children</article-title><source>Acta Paediatr</source><volume>107</volume><fpage>560</fpage><lpage>567</lpage><year>2018</year><pub-id pub-id-type="pmid">29247538</pub-id><pub-id pub-id-type="doi">10.1111/apa.14189</pub-id></element-citation></ref>
<ref id="b26-WASJ-7-1-00298"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eltorki</surname><given-names>M</given-names></name><name><surname>Busse</surname><given-names>JW</given-names></name><name><surname>Freedman</surname><given-names>SB</given-names></name><name><surname>Thompson</surname><given-names>G</given-names></name><name><surname>Beattie</surname><given-names>K</given-names></name><name><surname>Serbanescu</surname><given-names>C</given-names></name><name><surname>Carciumaru</surname><given-names>R</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Ali</surname><given-names>S</given-names></name></person-group><article-title>Intravenous ketorolac versus morphine in children presenting with suspected appendicitis: A pilot single-centre non-inferiority randomised controlled trial</article-title><source>BMJ Open</source><volume>12</volume><issue>e056499</issue><year>2022</year><pub-id pub-id-type="pmid">35383071</pub-id><pub-id pub-id-type="doi">10.1136/bmjopen-2021-056499</pub-id></element-citation></ref>
<ref id="b27-WASJ-7-1-00298"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neri</surname><given-names>E</given-names></name><name><surname>Maestro</surname><given-names>A</given-names></name><name><surname>Minen</surname><given-names>F</given-names></name><name><surname>Montico</surname><given-names>M</given-names></name><name><surname>Ronfani</surname><given-names>L</given-names></name><name><surname>Zanon</surname><given-names>D</given-names></name><name><surname>Favret</surname><given-names>A</given-names></name><name><surname>Messi</surname><given-names>G</given-names></name><name><surname>Barbi</surname><given-names>E</given-names></name></person-group><article-title>Sublingual ketorolac versus sublingual tramadol for moderate to severe post-traumatic bone pain in children: A double-blind, randomised, controlled trial</article-title><source>Arch Dis Child</source><volume>98</volume><fpage>721</fpage><lpage>724</lpage><year>2013</year><pub-id pub-id-type="pmid">23702435</pub-id><pub-id pub-id-type="doi">10.1136/archdischild-2012-303527</pub-id></element-citation></ref>
<ref id="b28-WASJ-7-1-00298"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanabar</surname><given-names>DJ</given-names></name></person-group><article-title>A clinical and safety review of paracetamol and ibuprofen in children</article-title><source>Inflammopharmacology</source><volume>25</volume><fpage>1</fpage><lpage>9</lpage><year>2017</year><pub-id pub-id-type="pmid">28063133</pub-id><pub-id pub-id-type="doi">10.1007/s10787-016-0302-3</pub-id></element-citation></ref>
<ref id="b29-WASJ-7-1-00298"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mak</surname><given-names>WY</given-names></name><name><surname>Yuen</surname><given-names>V</given-names></name><name><surname>Irwin</surname><given-names>M</given-names></name><name><surname>Hui</surname><given-names>T</given-names></name></person-group><article-title>Pharmacotherapy for acute pain in children: Current practice and recent advances</article-title><source>Expert Opin Pharmacother</source><volume>12</volume><fpage>865</fpage><lpage>881</lpage><year>2011</year><pub-id pub-id-type="pmid">21254863</pub-id><pub-id pub-id-type="doi">10.1517/14656566.2011.542751</pub-id></element-citation></ref>
<ref id="b30-WASJ-7-1-00298"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chumpitazi</surname><given-names>CE</given-names></name><name><surname>Chang</surname><given-names>C</given-names></name><name><surname>Atanelov</surname><given-names>Z</given-names></name><name><surname>Dietrich</surname><given-names>AM</given-names></name><name><surname>Lam</surname><given-names>SHF</given-names></name><name><surname>Rose</surname><given-names>E</given-names></name><name><surname>Ruttan</surname><given-names>T</given-names></name><name><surname>Shahid</surname><given-names>S</given-names></name><name><surname>Stoner</surname><given-names>MJ</given-names></name><name><surname>Sulton</surname><given-names>C</given-names></name><etal/></person-group><article-title>Managing acute pain in children presenting to the emergency department without opioids</article-title><source>J Am Coll Emerg Physicians Open</source><volume>3</volume><issue>e12664</issue><year>2022</year><pub-id pub-id-type="pmid">35310402</pub-id><pub-id pub-id-type="doi">10.1002/emp2.12664</pub-id></element-citation></ref>
<ref id="b31-WASJ-7-1-00298"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwenk</surname><given-names>ES</given-names></name><name><surname>Viscusi</surname><given-names>ER</given-names></name><name><surname>Buvanendran</surname><given-names>A</given-names></name><name><surname>Hurley</surname><given-names>RW</given-names></name><name><surname>Wasan</surname><given-names>AD</given-names></name><name><surname>Narouze</surname><given-names>S</given-names></name><name><surname>Bhatia</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>FN</given-names></name><name><surname>Hooten</surname><given-names>WM</given-names></name><name><surname>Cohen</surname><given-names>SP</given-names></name></person-group><article-title>Consensus guidelines on the use of intravenous ketamine infusions for acute pain management from the American society of regional anesthesia and pain medicine, the American academy of pain medicine, and the American society of anesthesiologists</article-title><source>Reg Anesth Pain Med</source><volume>43</volume><fpage>456</fpage><lpage>466</lpage><year>2018</year><pub-id pub-id-type="pmid">29870457</pub-id><pub-id pub-id-type="doi">10.1097/AAP.0000000000000806</pub-id></element-citation></ref>
<ref id="b32-WASJ-7-1-00298"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majidinejad</surname><given-names>S</given-names></name><name><surname>Esmailian</surname><given-names>M</given-names></name><name><surname>Emadi</surname><given-names>M</given-names></name></person-group><article-title>Comparison of intravenous ketamine with morphine in pain relief of long bones fractures: A double blind randomized clinical trial</article-title><source>Emerg (Tehran)</source><volume>2</volume><fpage>77</fpage><lpage>80</lpage><year>2014</year><pub-id pub-id-type="pmid">26495351</pub-id></element-citation></ref>
<ref id="b33-WASJ-7-1-00298"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlow</surname><given-names>N</given-names></name><name><surname>Schlaepfer</surname><given-names>CH</given-names></name><name><surname>Stoll</surname><given-names>CRT</given-names></name><name><surname>Doering</surname><given-names>M</given-names></name><name><surname>Carpenter</surname><given-names>CR</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Motov</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Schwarz</surname><given-names>ES</given-names></name></person-group><article-title>A systematic review and meta-analysis of ketamine as an alternative to opioids for acute pain in the emergency department</article-title><source>Acad Emerg Med</source><volume>25</volume><fpage>1086</fpage><lpage>1097</lpage><year>2018</year><pub-id pub-id-type="pmid">30019434</pub-id><pub-id pub-id-type="doi">10.1111/acem.13502</pub-id></element-citation></ref>
<ref id="b34-WASJ-7-1-00298"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balzer</surname><given-names>N</given-names></name><name><surname>McLeod</surname><given-names>SL</given-names></name><name><surname>Walsh</surname><given-names>C</given-names></name><name><surname>Grewal</surname><given-names>K</given-names></name></person-group><article-title>Low-dose ketamine for acute pain control in the emergency department: A systematic review and meta-analysis</article-title><source>Acad Emerg Med</source><volume>28</volume><fpage>444</fpage><lpage>454</lpage><year>2021</year><pub-id pub-id-type="pmid">33098707</pub-id><pub-id pub-id-type="doi">10.1111/acem.14159</pub-id></element-citation></ref>
<ref id="b35-WASJ-7-1-00298"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Díaz-Chávez</surname><given-names>EP</given-names></name><name><surname>Medina-Chávez</surname><given-names>JL</given-names></name><name><surname>Avalos-González</surname><given-names>J</given-names></name><name><surname>Hernández-Moreno</surname><given-names>JJ</given-names></name><name><surname>Cabrera-Mendoza</surname><given-names>AU</given-names></name><name><surname>Trujillo-Hernández</surname><given-names>B</given-names></name></person-group><article-title>Comparison of sublingual ketorolac vs IV metamizole in the management of pain after same-day surgery</article-title><source>Cir Cir</source><volume>77</volume><fpage>45</fpage><lpage>49</lpage><year>2009</year><pub-id pub-id-type="pmid">19344563</pub-id><comment>(In Spanish)</comment></element-citation></ref>
<ref id="b36-WASJ-7-1-00298"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minkowitz</surname><given-names>HS</given-names></name><name><surname>Singla</surname><given-names>NK</given-names></name><name><surname>Evashenk</surname><given-names>MA</given-names></name><name><surname>Hwang</surname><given-names>SS</given-names></name><name><surname>Chiang</surname><given-names>YK</given-names></name><name><surname>Hamel</surname><given-names>LG</given-names></name><name><surname>Palmer</surname><given-names>PP</given-names></name></person-group><article-title>Pharmacokinetics of sublingual sufentanil tablets and efficacy and safety in the management of postoperative pain</article-title><source>Reg Anesth Pain Med</source><volume>38</volume><fpage>131</fpage><lpage>139</lpage><year>2013</year><pub-id pub-id-type="pmid">23271030</pub-id><pub-id pub-id-type="doi">10.1097/AAP.0b013e3182791157</pub-id></element-citation></ref>
<ref id="b37-WASJ-7-1-00298"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borland</surname><given-names>M</given-names></name><name><surname>Jacobs</surname><given-names>I</given-names></name><name><surname>King</surname><given-names>B</given-names></name><name><surname>O'Brien</surname><given-names>D</given-names></name></person-group><article-title>A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department</article-title><source>Ann Emerg Med</source><volume>49</volume><fpage>335</fpage><lpage>340</lpage><year>2007</year><pub-id pub-id-type="pmid">17067720</pub-id><pub-id pub-id-type="doi">10.1016/j.annemergmed.2006.06.016</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-WASJ-7-1-00298" position="float">
<label>Figure 1</label>
<caption><p>Flow chart depicting the management of a child with severe pain. NRS, Numerical Rating Scale; FLACC, Face, Legs, Activity, Cry, and Consolability (FLACC) scale; NSAIDs, non-steroidal anti-inflammatory drugs.</p></caption>
<graphic xlink:href="wasj-07-01-00298-g00.tif"/>
</fig>
<table-wrap id="tI-WASJ-7-1-00298" position="float">
<label>Table I</label>
<caption><p>Acute pain scales.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Scale name</th>
<th align="center" valign="middle">Type of scale</th>
<th align="center" valign="middle">Age</th>
<th align="center" valign="middle">Scoring system</th>
<th align="center" valign="middle">Scale</th>
<th align="center" valign="middle">Indications</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Faces Pain Rating Scale</td>
<td align="left" valign="middle">Self-evaluation</td>
<td align="left" valign="middle">4-8 years</td>
<td align="left" valign="middle">Picture-based scale where child select 1 of 6 faces to represent their pain experience</td>
<td align="left" valign="middle">0-10 (0-3 mild, 4-6 moderate, 7-10 severe)</td>
<td align="left" valign="middle">Cognitively adequate child with motor impairment</td>
</tr>
<tr>
<td align="left" valign="middle">Numerical Rating Scale (NRS)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">&gt;8 years</td>
<td align="left" valign="middle">Ask the patient to assign a number to their pain (0 no pain, 10 worst pain ever)</td>
<td align="left" valign="middle">0-10 (0-3 mild, 4-6 moderate, 7-10 severe)</td>
<td align="left" valign="middle">Cognitively adequate child without motor impairment</td>
</tr>
<tr>
<td align="left" valign="middle">FLACC (Face Legs Activity Cry Consolability)</td>
<td align="left" valign="middle">Hetero-valuation</td>
<td align="left" valign="middle">0-3 years</td>
<td align="left" valign="middle">5 Behaviour items each scored from 0 to 2 to a total of 10 points</td>
<td align="left" valign="middle">0-10 (0-3 mild, 4-6 moderate, 7-10 severe)</td>
<td align="center" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">FLACC-R (Revised)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">2 months-7 years or any age nonverbal or with intellectual impairment</td>
<td align="left" valign="middle">Compared to ‘FLACC’ includes additional pain behaviours often found in children who are non-verbal or with cognitive impairment</td>
<td align="left" valign="middle">0-10 (0-3 mild, 4-6 moderate, ≥7 severe)</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">NCCPC-R (Non-Communicating Children's Pain Checklist-Revised)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">3-18 years</td>
<td align="left" valign="middle">Scale with 30 total items with 7 subscales (vocal, social, facial, activity, body and limbs, physiological, and eating/sleeping) each item scored from 0 to 3 according to the frequency of its occurrence.</td>
<td align="left" valign="middle">Total score of ≥7 indicates pain.</td>
<td align="left" valign="middle">Children with cognitive impairment, non-verbal or unable by age to provide pain self-assessment</td>
</tr>
<tr>
<td align="left" valign="middle">PPP (Pediatric Pain Profile)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">1-18 years</td>
<td align="left" valign="middle">Two-part individualized measure allowing caregivers to describe their child's pain behaviours on good days and bad days and complete a 20-item measure scored on a 0-3 scale</td>
<td align="left" valign="middle">Total score of ≥14 indicates clinically significant pain, 10-19 is mild, 20-29 is moderate, 30-39 is severe, and &gt;40 is very severe pain.</td>
<td align="center" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">EVENDOL (EValuation ENfant DOuLeur)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">0-7 years</td>
<td align="left" valign="middle">Five items (vocal or verbal expression, Facial expression, movements, postures, interaction with the environment) evaluated at rest and at mobilization,</td>
<td align="left" valign="middle">Total score ranges from 0 to 15. Treatment threshold ≥4</td>
<td align="center" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">Color Analogue Scale (CAS)</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">4-10 years</td>
<td align="left" valign="middle">Gradations in colour, area and length so as to easily associate scale positions with diffused levels of pain intensity</td>
<td align="left" valign="middle">The back of the tool has a numerical rating scale providing means to assign a numerical pain score between 1 and 10 cm in 0,25 cm increment</td>
<td align="center" valign="middle"> </td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>The information listed in the table has been obtained from previous studies (<xref rid="b1-WASJ-7-1-00298" ref-type="bibr">1</xref>,<xref rid="b3-WASJ-7-1-00298" ref-type="bibr">3</xref>,<xref rid="b8-WASJ-7-1-00298" ref-type="bibr">8</xref>).</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-WASJ-7-1-00298" position="float">
<label>Table II</label>
<caption><p>Non-pharmacological therapy.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Type of method</th>
<th align="center" valign="middle">Age</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Physical methods</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">     Comforting touch (cuddles, stroking, holding)</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Comfort positioning</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Cutaneous stimulation</td>
<td align="left" valign="middle">&gt;1 months</td>
</tr>
<tr>
<td align="left" valign="middle">     Pressure/massage</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Hot/cold treatments</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Pacifier and sucrose solution</td>
<td align="left" valign="middle">&lt;1 years</td>
</tr>
<tr>
<td align="left" valign="middle">Cognitive-comportamental methods</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">     Information/communication</td>
<td align="left" valign="middle">&gt;6 years</td>
</tr>
<tr>
<td align="left" valign="middle">     Psychological preparations</td>
<td align="left" valign="middle">&gt;6 years</td>
</tr>
<tr>
<td align="left" valign="middle">     Direct involvement in pain management/assessment</td>
<td align="left" valign="middle">&gt;6 years</td>
</tr>
<tr>
<td align="left" valign="middle">     Distraction tools (music, videos, apps, toys with light/sounds)</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Desensitization</td>
<td align="left" valign="middle">&gt;2 years</td>
</tr>
<tr>
<td align="left" valign="middle">     View/imagery (story-telling, guided imagery, favor activity)</td>
<td align="left" valign="middle">&gt;6 years</td>
</tr>
<tr>
<td align="left" valign="middle">     Relaxation (deep breathing, music, muscles relaxing)</td>
<td align="left" valign="middle">All ages</td>
</tr>
<tr>
<td align="left" valign="middle">     Breathing out/controlled breathing</td>
<td align="left" valign="middle">Teenagers</td>
</tr>
</tbody>
</table>
</table-wrap>
<table-wrap id="tIII-WASJ-7-1-00298" position="float">
<label>Table III</label>
<caption><p>Pharmacological therapies for acute pain.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Drug</th>
<th align="center" valign="middle">Route of administration</th>
<th align="center" valign="middle">Single dose</th>
<th align="center" valign="middle">Maximum dose</th>
<th align="center" valign="middle">Indications</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Non-opioids</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">     Paracetamol</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">10-15 mg/kg, every 4-6 h</td>
<td align="left" valign="middle">60-75 mg/kg/die (4 g/die)</td>
<td align="left" valign="middle">From birth</td>
</tr>
<tr>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">Rectal</td>
<td align="left" valign="middle">15-20 mg/kg, every 4-6 h</td>
<td align="left" valign="middle">60-90 mg/kg/die</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">i.v.</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle"><italic>90 g</italic>/kg/die</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">     NSAIDs</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">          Ibuprofen</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">5-10 mg/kg, every 6-8 h</td>
<td align="left" valign="middle">20-30 mg/kg/die</td>
<td align="left" valign="middle">&gt;3 months</td>
</tr>
<tr>
<td align="left" valign="middle">          Ketoprofen</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">1-3 mg/kg, every 8-12 h</td>
<td align="left" valign="middle">4-9 mg/kg/die</td>
<td align="left" valign="middle">&gt;6 years</td>
</tr>
<tr>
<td align="left" valign="middle">          Ketorolac</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">0.5 mg/kg, every 6-8 h</td>
<td align="left" valign="middle">3 g/kg/die</td>
<td align="left" valign="middle">&gt;16 years</td>
</tr>
<tr>
<td align="left" valign="middle">          Naproxen sodium</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">1 mg/kg, every 8 h</td>
<td align="left" valign="middle">3 g/kg/die</td>
<td align="left" valign="middle">&gt;14 years</td>
</tr>
<tr>
<td align="left" valign="middle">          Acetylsalicylic acid</td>
<td align="left" valign="middle">i.v.</td>
<td align="left" valign="middle">5-10 mg/kg, every 8-12 h</td>
<td align="left" valign="middle">20 g/kg/die</td>
<td align="left" valign="middle">Not indicated in pediatric age. If necessary &gt;2 years</td>
</tr>
<tr>
<td align="left" valign="middle">Opioids</td>
<td align="left" valign="middle"><italic>Per os</italic> (i.v.)</td>
<td align="left" valign="middle">10 mg/kg, every 6-8 h</td>
<td align="left" valign="middle">80 g/kg/die</td>
<td align="left" valign="middle">&gt;16 years</td>
</tr>
<tr>
<td align="left" valign="middle">     Weak</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">          Codeine</td>
<td align="left" valign="middle"><italic>Per os</italic> or rectal</td>
<td align="left" valign="middle">0.5-1 mg/kg, every 6-8 h</td>
<td align="left" valign="middle">240 mg/die</td>
<td align="left" valign="middle">&gt;12 years</td>
</tr>
<tr>
<td align="left" valign="middle">          Tramadol hydrochloride</td>
<td align="left" valign="middle"><italic>Per os</italic></td>
<td align="left" valign="middle">1-2 mg/kg, every 6-8 h</td>
<td align="left" valign="middle">400 mg/die</td>
<td align="left" valign="middle">&gt;1 year</td>
</tr>
<tr>
<td align="left" valign="middle">     Strong</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">          Fast-release morphine sulfate</td>
<td align="left" valign="middle">i.v.</td>
<td align="left" valign="middle">0.15-0.3 mg/kg, every 4 h</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">&gt;1 year</td>
</tr>
<tr>
<td align="left" valign="middle">          Morphine hydrochloride</td>
<td align="left" valign="middle">i.v.</td>
<td align="left" valign="middle">Bolus 0.05-0.1 mg/kg, every 2-4 h</td>
<td align="left" valign="middle">5 mg/dose</td>
<td align="left" valign="middle">From birth</td>
</tr>
<tr>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">CI 0.02-0.03 mg/kg/h</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle">          Fentanyl</td>
<td align="left" valign="middle">Intra nasal injections</td>
<td align="left" valign="middle">1-2 µg/kg/dose (repeatable after 30-60 min)</td>
<td align="left" valign="middle">100 µg</td>
<td align="left" valign="middle"> </td>
</tr>
<tr>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">i.v.</td>
<td align="left" valign="middle">Bolus 0.001-0.002 mg/kg; CI 0.001 mg/kg/h</td>
<td align="left" valign="middle"> </td>
<td align="left" valign="middle">&gt;2 years</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>The information listed in the table has been obtained from previous studies (<xref rid="b31-WASJ-7-1-00298 b32-WASJ-7-1-00298 b33-WASJ-7-1-00298 b34-WASJ-7-1-00298 b35-WASJ-7-1-00298 b36-WASJ-7-1-00298 b37-WASJ-7-1-00298" ref-type="bibr">31-37</xref>).</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
